US FDA will convene a daylong workshop Sept. 23 to get feedback on two recent draft guidances dealing with the agency's thinking on next-generation sequencing diagnostics, or NGS tests.
While the workshop will be webcast, those wanting to attend the meeting at NIH headquarters in Bethesda, Md., in person must sign up by Sept. 13. FDA says...